- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in Age-Related Macular Degeneration Therapies
Authors
Keywords
-
Journal
MOLECULES
Volume 27, Issue 16, Pages 5089
Publisher
MDPI AG
Online
2022-08-11
DOI
10.3390/molecules27165089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global Incidence, Progression, and Risk Factors of Age-Related Macular Degeneration and Projection of Disease Statistics in 30 Years: A Modeling Study
- (2021) Yuye Wang et al. GERONTOLOGY
- Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration
- (2021) Reshal Suri et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- A Systematic Review of Carotenoids in the Management of Age-Related Macular Degeneration
- (2021) Drake W. Lem et al. Antioxidants
- Angiopoietins as Potential Targets in Management of Retinal Disease
- (2021) Arshad M Khanani et al. Clinical Ophthalmology
- Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data
- (2020) Hansjürgen Agostini et al. CURRENT EYE RESEARCH
- Risk factors for progression of age‐related macular degeneration
- (2020) Thomas J Heesterbeek et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
- (2020) Baruch D. Kuppermann et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The interpretation of China national essential medicines list 2018
- (2020) Wei Zuo et al. Expert Review of Clinical Pharmacology
- Risuteganib—a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema
- (2020) Lincoln T. Shaw et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration
- (2020) Derek Kunimoto et al. OPHTHALMOLOGY
- Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration
- (2020) Victor A. Eng et al. PLoS One
- Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
- (2020) Kuei-Ju Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities
- (2020) Christopher L. Cioffi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities
- (2020) Priyatham S. Mettu et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration: Studies in Japan and the United States
- (2019) Derek Kunimoto et al. Ophthalmic Surgery Lasers & Imaging Retina
- Complement inhibition as a therapeutic strategy in retinal disorders
- (2019) Enoch Kassa et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti‐VEGF‐A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study
- (2019) Anne Wolf et al. EMBO Molecular Medicine
- Emerging PEGylated non-biologic drugs
- (2019) Eun Ji Park et al. EXPERT OPINION ON EMERGING DRUGS
- Brivanib, a multitargeted small‐molecule tyrosine kinase inhibitor, suppresses laser‐induced CNV in a mouse model of neovascular AMD
- (2019) Lele Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration.
- (2019) David S. Liao et al. OPHTHALMOLOGY
- The Challenges and Promise of Complement Therapeutics for Ocular Diseases
- (2019) Dong Ho Park et al. Frontiers in Immunology
- Mitochondrial oxidative stress in the retinal pigment epithelium (RPE) led to metabolic dysfunction in both the RPE and retinal photoreceptors
- (2019) Emily E. Brown et al. Redox Biology
- Subretinal Transplantation of Human Central Nervous System Stem Cells Stimulates Controlled Proliferation of Endogenous Retinal Pigment Epithelium
- (2019) Trevor J. McGill et al. Translational Vision Science & Technology
- Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis
- (2019) Jeany Q. Li et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions
- (2019) Agnes Lipecz et al. GeroScience
- A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration
- (2018) Younghwa Shin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Peroxisome Proliferated Activated Receptors (PPARs): Opportunities and Challenges for Ocular Therapy
- (2018) Prachi Khatol et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD
- (2018) Xian Wei et al. EXPERIMENTAL EYE RESEARCH
- Pharmacotherapy of retinal disease with visual cycle modulators
- (2018) Rehan M. Hussain et al. EXPERT OPINION ON PHARMACOTHERAPY
- Elusive drusen and changing terminology of AMD
- (2018) P. T. V. M. De Jong EYE
- Clinical pharmacology of intravitreal anti-VEGF drugs
- (2018) Stefano Fogli et al. EYE
- Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
- (2018) Norman Waugh et al. HEALTH TECHNOLOGY ASSESSMENT
- The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration
- (2018) Christopher M. Adams et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of facile drug delivery platform of ranibizumab fabricated PLGA-PEGylated magnetic nanoparticles for age-related macular degeneration therapy
- (2018) Jian Yan et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN
- (2018) Qinyuan Xu et al. Lipids in Health and Disease
- Properdin: A multifaceted molecule involved in inflammation and diseases
- (2018) Jin Y. Chen et al. MOLECULAR IMMUNOLOGY
- Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration
- (2018) Philip J. Rosenfeld et al. OPHTHALMOLOGY
- A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer’s disease
- (2018) Kameran Lashkari et al. PLoS One
- Conbercept for patients with age-related macular degeneration: a systematic review
- (2018) Jiaxing Zhang et al. BMC Ophthalmology
- Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization
- (2018) Gloriane Schnabolk et al. Molecular Therapy-Methods & Clinical Development
- Stargardt macular dystrophy and evolving therapies
- (2018) Rehan M. Hussain et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial
- (2018) Antonia M. Joussen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
- (2018) David Callanan et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
- (2018) Ruslan Grishanin et al. MOLECULAR THERAPY
- Induced pluripotent stem cell-based therapy for age-related macular degeneration
- (2017) Peter Bracha et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option
- (2017) M Ashraf et al. EYE
- Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
- (2017) Kyoungmi Kim et al. GENOME RESEARCH
- Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
- (2017) Peter A. Campochiaro et al. HUMAN GENE THERAPY
- The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation
- (2017) Samir M. Parikh JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- PPARγ agonists: Potential treatments for exudative age-related macular degeneration
- (2017) Alexandre Vallée et al. LIFE SCIENCES
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
- (2017) Glenn J. Jaffe et al. OPHTHALMOLOGY
- The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD
- (2017) Sayantan Datta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
- (2017) David S. Boyer et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
- (2017) Brian L. Yaspan et al. Science Translational Medicine
- Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration
- (2017) Timothy L. Jackson et al. JAMA Ophthalmology
- Recent developments in age-related macular degeneration: a review
- (2017) Waseem Al-Zamil et al. Clinical Interventions in Aging
- PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration
- (2016) Mayur Choudhary et al. Aging-US
- Inflammation and its role in age-related macular degeneration
- (2016) Anu Kauppinen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models
- (2016) Anand Giddabasappa et al. EXPERIMENTAL EYE RESEARCH
- Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs
- (2016) Michael J. Koss et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- Vue d’ensemble des pratiques médicales dans la DMLA exsudative en France
- (2016) H. Massé et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Repressed SIRT1/PGC-1α pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration
- (2016) Nady Golestaneh et al. Journal of Translational Medicine
- Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases
- (2016) Allan Lançon et al. MOLECULES
- An eye to the future: Researchers debate best path for stem cell–derived therapies
- (2016) Shraddha Chakradhar NATURE MEDICINE
- Infrared reflectance imaging in age-related macular degeneration
- (2016) Angelica Ly et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives
- (2016) Ricardo Costa et al. Drug Design Development and Therapy
- A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy
- (2016) Rania S. Sulaiman et al. Scientific Reports
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions
- (2016) Rajan Saini et al. Cancers
- Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study
- (2015) Glenn J. Jaffe et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation
- (2015) Alexander Scholz et al. Annals of the New York Academy of Sciences
- Molecular pharmacodynamics of emixustat in protection against retinal degeneration
- (2015) Jianye Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease
- (2015) Christopher L. Cioffi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
- (2015) Steven D Schwartz et al. LANCET
- Quaternary Alkylammonium Conjugates of Steroids: Synthesis, Molecular Structure, and Biological Studies
- (2015) Bogumił Brycki et al. MOLECULES
- Outer Retinal Tubulation as a Predictor of the Enlargement Amount of Geographic Atrophy in Age-Related Macular Degeneration
- (2015) Amirhossein Hariri et al. OPHTHALMOLOGY
- Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration
- (2015) Karl G. Csaky et al. OPHTHALMOLOGY
- Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration
- (2015) Charles C. Wykoff et al. OPHTHALMOLOGY
- Age-Related Macular Degeneration
- (2015) Sonia Mehta PRIMARY CARE
- Stem cell based therapies for age-related macular degeneration: The promises and the challenges
- (2015) Hossein Nazari et al. PROGRESS IN RETINAL AND EYE RESEARCH
- PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, 90-DAY STUDY OF EMIXUSTAT HYDROCHLORIDE IN GEOGRAPHIC ATROPHY ASSOCIATED WITH DRY AGE-RELATED MACULAR DEGENERATION
- (2015) Pravin U. Dugel et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Profile of conbercept in the treatment of neovascular age-related macular degeneration
- (2015) Xiaodong Sun et al. Drug Design Development and Therapy
- Effect of curcumin on aging retinal pigment epithelial cells
- (2015) Jiong Lu et al. Drug Design Development and Therapy
- Future Therapies of Wet Age-Related Macular Degeneration
- (2015) Makoto Ishikawa et al. Journal of Ophthalmology
- Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration
- (2015) Thanh T Nguyen et al. Expert Review of Clinical Pharmacology
- Nitroxide pharmaceutical development for age-related degeneration and disease
- (2015) Jacob A. Zarling et al. Frontiers in Genetics
- First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer’s Disease: A Randomized, Placebo-Controlled Study
- (2015) Niels Andreasen et al. PLoS One
- Visual Cycle Modulation as an Approach toward Preservation of Retinal Integrity
- (2015) Claes Bavik et al. PLoS One
- Drugs in Phase II clinical trials for the treatment of age-related macular degeneration
- (2014) Michael John Tolentino et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial
- (2014) P. A. Petrou et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease
- (2014) Christopher L. Cioffi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer’s Disease (AD) and Age-Related Macular Degeneration (AMD)
- (2014) Yuhai Zhao et al. MOLECULAR NEUROBIOLOGY
- Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
- (2014) John A Zuris et al. NATURE BIOTECHNOLOGY
- Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration
- (2014) Antje Biesemeier et al. NEUROBIOLOGY OF AGING
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
- (2014) Allen C. Ho et al. OPHTHALMOLOGY
- Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration
- (2014) Xiaoxin Li et al. OPHTHALMOLOGY
- Geographic Atrophy
- (2014) Frank G. Holz et al. OPHTHALMOLOGY
- Tumorigenicity Studies of Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) for the Treatment of Age-Related Macular Degeneration
- (2014) Hoshimi Kanemura et al. PLoS One
- CLINICAL EVALUATION OF PAZOPANIB EYE DROPS IN HEALTHY SUBJECTS AND IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2014) Rishi Singh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Overview of fundamental study of pazopanib in cancer
- (2014) Hong-Lin Zhao et al. Thoracic Cancer
- Nutritional Risk Factors for Age-Related Macular Degeneration
- (2014) Lebriz Ersoy et al. Biomed Research International
- Age-Related Macular Degeneration: Pathogenesis, Genetic Background, and the Role of Nutritional Supplements
- (2014) Marilita M. Moschos et al. Journal of Chemistry
- E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts
- (2014) Armin Wiegering et al. NEOPLASIA
- Cellular and molecular mechanisms of age-related macular degeneration: From impaired autophagy to neovascularization
- (2013) Alexa Klettner et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mechanisms of age-related macular degeneration and therapeutic opportunities
- (2013) Menno van Lookeren Campagne et al. JOURNAL OF PATHOLOGY
- Global Prevalence of Vision Impairment and Blindness
- (2013) Gretchen A. Stevens et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
- (2013) Laurent Kodjikian et al. OPHTHALMOLOGY
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
- (2013) Zohar Yehoshua et al. OPHTHALMOLOGY
- Age-Related Macular Degeneration
- (2013) Lily K. Cheung et al. PHARMACOTHERAPY
- TNF-α Decreases VEGF Secretion in Highly Polarized RPE Cells but Increases It in Non-Polarized RPE Cells Related to Crosstalk between JNK and NF-κB Pathways
- (2013) Hiroto Terasaki et al. PLoS One
- CNTF-mediated protection of photoreceptors requires initial activation of the cytokine receptor gp130 in Muller glial cells
- (2013) K. D. Rhee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PHASE 1, DOSE-RANGING STUDY OF EMIXUSTAT HYDROCHLORIDE (ACU-4429), A NOVEL VISUAL CYCLE MODULATOR, IN HEALTHY VOLUNTEERS
- (2013) Ryo Kubota et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Initial Exploration of Oral Pazopanib in Healthy Participants and Patients With Age-Related Macular Degeneration
- (2013) Megan M. McLaughlin et al. JAMA Ophthalmology
- Update on current and future novel therapies for dry age-related macular degeneration
- (2013) Ella Leung et al. Expert Review of Clinical Pharmacology
- Vitamin A Metabolism in Rod and Cone Visual Cycles
- (2012) John C. Saari Annual Review of Nutrition
- Antiangiogenic Effects of Axitinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase, on Laser-Induced Choroidal Neovascularization in Mice
- (2012) Seungbum Kang et al. CURRENT EYE RESEARCH
- Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration
- (2012) Trevor J. McGill et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Effects of low concentrations of Regorafenib and Sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro
- (2012) Brian I. Carr et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Embryonic stem cell trials for macular degeneration: a preliminary report
- (2012) Steven D Schwartz et al. LANCET
- Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration
- (2012) Teresa Diago et al. MAYO CLINIC PROCEEDINGS
- Mechanisms of Age-Related Macular Degeneration
- (2012) Jayakrishna Ambati et al. NEURON
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- The Age-related Eye Disease Study 2 (AREDS2)
- (2012) Emily Y. Chew et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Suppression of Experimental Choroidal Neovascularization by Curcumin in Mice
- (2012) Ping Xie et al. PLoS One
- CURRENT KNOWLEDGE AND TRENDS IN AGE-RELATED MACULAR DEGENERATION
- (2012) Raul Velez-Montoya et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INVESTIGATION OF ORAL FENRETINIDE FOR TREATMENT OF GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION
- (2012) Nathan L. Mata et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
- (2012) Young Gun Park et al. Journal of Ophthalmology
- Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
- (2011) Elizabeth Allen et al. CLINICAL CANCER RESEARCH
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of Major Eye Diseases Leading to Blindness in Europe: A Literature Review
- (2011) Elena Prokofyeva et al. OPHTHALMIC RESEARCH
- Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration
- (2011) J.-D. Ding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SAFETY AND EFFECT ON ROD FUNCTION OF ACU-4429, A NOVEL SMALL-MOLECULE VISUAL CYCLE MODULATOR
- (2011) Ryo Kubota et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RANDOMIZED CLINICAL TRIAL FRANCE DMLA2
- (2011) Salomon-Yves Cohen et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Human Induced Pluripotent Stem-Derived Retinal Pigment Epithelium (RPE) Cells Exhibit Ion Transport, Membrane Potential, Polarized Vascular Endothelial Growth Factor Secretion, and Gene Expression Pattern Similar to Native RPE
- (2011) Maria Kokkinaki et al. STEM CELLS
- The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects
- (2010) Berthold Pemp et al. ACTA OPHTHALMOLOGICA
- Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF
- (2010) M. Kernt et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Biodegradable Intraocular Therapies for Retinal Disorders
- (2010) Noriyuki Kuno et al. DRUGS & AGING
- Pilot Study of Safety and Effect of Combined Intravitreal Bevacizumab and Methotrexate for Neovascular Age-Related Macular Degeneration
- (2010) Masoud Soheilian et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases
- (2010) R. S. Bhide et al. MOLECULAR CANCER THERAPEUTICS
- A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration
- (2010) Ming Zhang et al. OPHTHALMOLOGY
- CNTF Induces Regeneration of Cone Outer Segments in a Rat Model of Retinal Degeneration
- (2010) Yiwen Li et al. PLoS One
- Abundant Lipid and Protein Components of Drusen
- (2010) Lan Wang et al. PLoS One
- Intravitreal methotrexate in therapeutically resistant exudative age-related macular degeneration
- (2009) Shree K. Kurup et al. ACTA OPHTHALMOLOGICA
- Autophagy, exosomes and drusen formation in age-related macular degeneration
- (2009) Ai Ling Wang et al. Autophagy
- Weekly Vaccination with Copaxone (Glatiramer Acetate) as a Potential Therapy for Dry Age-Related Macular Degeneration
- (2009) Gennady Landa et al. CURRENT EYE RESEARCH
- The dynamic nature of Bruch's membrane
- (2009) J.C. Booij et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Effect of systemic moxaverine on ocular blood flow in humans
- (2008) Hemma Resch et al. ACTA OPHTHALMOLOGICA
- Napoleone Ferrara and the Saga of Vascular Endothelial Growth Factor
- (2008) Domenico Ribatti ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH
- Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis
- (2008) J Evans EYE
- Curcumin protects retinal cells from light-and oxidant stress-induced cell death
- (2008) Md Nawajes A. Mandal et al. FREE RADICAL BIOLOGY AND MEDICINE
- Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib® treatment
- (2007) Marcus Kernt et al. ACTA OPHTHALMOLOGICA
- Retinal Precursors and the Development of Geographic Atrophy in Age-Related Macular Degeneration
- (2007) Michael L. Klein et al. OPHTHALMOLOGY
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
- (2007) Tien Wong et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started